32.93
price down icon0.09%   -0.03
after-market After Hours: 33.25 0.32 +0.97%
loading

Exelixis Inc Stock (EXEL) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-29 2023-12-29 2023-09-29 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
11.35%
425.23
479.65 471.92 469.85 408.79
Cost Of Revenue
2.28%
21.26
21.75 18.77 17.70 14.31
Gross Profit
11.78%
403.97
457.90 453.15 452.14 394.47
Operating Expenses
0.43%
374.51
376.11 470.73 374.29 365.64
Benefits Costs and Expenses
0.53%
395.76
397.86 489.50 392.00 379.96
Costs And Expenses
0.53%
395.76
397.86 489.50 392.00 379.96
Operating Income/Loss
63.98%
29.46
81.79 -17.58 77.85 28.83
Income/Loss From Continuing Operations Before Tax
63.98%
29.46
81.79 -17.58 77.85 28.83
Income Tax Expense/Benefit
31.80%
11.95
17.52 4.777 19.21 8.25
Income/Loss From Continuing Operations After Tax
56.36%
37.32
85.52 1.041 81.18 40.03
Net Income/Loss
56.36%
37.32
85.52 1.041 81.18 40.03
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
9,434%
300.76
-3.222 315.50 324.20 324.42
Diluted Average Shares
10,961%
305.53
-2.813 319.25 327.31 326.28
Basic Earnings Per Share
55.56%
0.12
0.27 - 0.25 0.12
Diluted Earnings Per Share
55.56%
0.12
0.27 - 0.25 0.12
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Cap:     |  Volume (24h):